Yaling Li

Mrs. Yaling Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
MFMing Fang
Ming Fang
YLYaling Li
Yaling Li
PWPeng Wang
Peng Wang
YWYanan Wang
Yanan Wang
XWXiaoqian Wang
Xiaoqian Wang
LYLiu Yongqi
Liu Yongqi
The efficacy of immunotherapy targeting PD-1/PD-L1 in gastric cancer depends on PD-L1 expression levels and the infiltration of immune cells within the tumor microenvironment (TME). Although methyltransferase-like 3 (METTL3) plays a role in the development and progression of gastric cancer, its mechanism of regulating the TME in gastric cancer remains unclear. In this study, we demonstrated that the expression of PD-L1 is regulated by METTL3. We found that METTL3 mediated N6-methyladenosine (m6A) modification of PDL1 mRNA in the 3′ untranslated region and induced mRNA degradation through an m6A/YTHDF2-dependent pathway in human gastric cancer cells. METTL3 knockdown or inhibition in gastric cancer cells significantly enhanced Jurkat cell migration and cytotoxic activity. In clinical gastric cancer tissue, a negative correlation was observed between the expression levels of PD-L1 and those of METTL3 or YTHDF2. In vivo, combination treatment with the METTL3 inhibitor STM2457 and PD-1 mAb resulted in a significant reduction in tumor growth, enhanced PD-L1 expression, and increased infiltration of CD8+ T cells. Finally, lower METTL3 expression in tumors correlated with improved sensitivity to anti–PD-1 immunotherapy in patients. Our findings revealed that METTL3-mediated m6A modification of PDL1 mRNA levels represents an epigenetic mechanism regulating antitumor immunity in gastric cancer, and inhibiting METTL3 during PD-1 mAb treatment reshaped the TME, thereby establishing a promising treatment approach for enhancing immunotherapy efficacy in patients with gastric cancer.

1 October 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
LXLing Xue
Ling Xue
PWPingfan Wu
Pingfan Wu
XZXiaowen Zhao
Xiaowen Zhao
XJXiaojie Jin
Xiaojie Jin
JWJingjing Wang
Jingjing Wang
CLChangtian Li
Changtian Li
Background: Cutaneous melanoma is a highly malignant skin tumor, and most patients have a poor prognosis. In recent years, immunotherapy has assumed an important role in the treatment of advanced cutaneous melanoma, but only a small percentage of patients benefit from immunotherapy. A growing number of studies have demonstrated that the prognosis of patients with cutaneous melanoma is closely related to long non-coding RNA and the tumor immune microenvironment. Methods: We downloaded RNA expression data and immune-related gene lists of cutaneous melanoma patients separately from The Cancer Genome Atlas database and ImmPort website and identified immune-related lncRNAs by co-expression analysis. The prognostic model was constructed by applying least absolute shrinkage and selection operator regression, and all patients were classified into high- and low-risk groups according to the risk score of the model. We evaluated the differences between the two groups in terms of survival outcomes, immune infiltration, pathway enrichment, chemotherapeutic drug sensitivity and immune checkpoint gene expression to verify the impact of lncRNA signature on clinical prognosis and immunotherapy efficacy. Results: By correlation analysis and LASSO regression analysis, we constructed an immune-related lncRNA prognostic model based on five lncRNA: HLA-DQB1-AS1, MIR205HG, RP11-643G5.6, USP30-AS1 and RP11-415F23.4. Based on this model, we plotted Kaplan–Meier survival curves and time-dependent ROC curves and analyzed its ability as an independent prognostic factor for cutaneous melanoma in combination with clinicopathological features. The results showed that these lncRNA signature was an independent prognostic factor of cutaneous melanoma with favorable prognostic ability. Our results also show a higher degree of immune infiltration, higher expression of immune checkpoint-associated genes, and better outcome of immunotherapy in the low-risk group of the lncRNA signature. Conclusion: The 5 immune-related lncRNA signatures constructed in our study can predict the prognosis of cutaneous melanoma and contribute to the selection of immunotherapy.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YSYali She
Yali She
XZXiaowen Zhao
Xiaowen Zhao
PWPingfan Wu
Pingfan Wu
LXLing Xue
Ling Xue
SWShengfang Wan
Shengfang Wan
YLYaling Li
Yaling Li
Background. Gastric cancer (GC) is the fifth most common malignant tumor and the third leading cause of cancer‐related deaths. Because GC has the characteristics of high heterogeneity, unclear mechanism, limited treatment methods, and low five‐year survival rate, it is necessary to find the prognostic biomarkers of GC and explore the mechanism of GC. Methods. We first identified differentially expressed genes (DEGs) between gastric cancer and normal gastric cells through expression analysis. A protein‐protein interaction (PPI) network was constructed to find tightly connected modules. We performed survival analysis on the DEGs in the modules to identify genes with prognostic significance. Gene set enrichment analysis (GSEA) was used to identify gene enrichment pathways. Finally, we used our own collected clinical samples of 119 gastric adenocarcinoma (STAD) tissues and 40 normal gastric tissues to perform immunohistochemical (IHC) staining to verify the differential expression of COL8A1 in STAD tissues and normal gastric tissues and its correlation with epithelial‐mesenchymal transition‐ (EMT‐) related factors. Results. We identified 356 DEGs through differential expression analysis. Through PPI analysis and survival analysis, we determined that the collagen type VII alpha‐1 chain (COL8A1) gene has prognostic significance. GSEA analysis showed that COL8A1 was significantly enriched in the EMT. IHC results showed that COL8A1 was upregulated in STAD tissues and could be used as an independent prognostic factor and was related to EMT. Conclusion. This study shows that COL8A1 is related to the prognosis of GC patients and might affect the progress of GC through the EMT pathway. Therefore, COL8A1 may be a biomarker for predicting the prognosis of GC.

29 July 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
YAYong An
Yong An
YZYucen Zhou
Yucen Zhou
LZLinghua Zhang
Linghua Zhang
ZQZhengze Qiang
Zhengze Qiang
LLLepeng Li
Lepeng Li
PWPeng Wang
Peng Wang
Accurate monitoring of Cu2+ and H2S levels is one of the most reliable methods for diagnosing tumors and assessing treatment efficacy. However, the development of fluorescent probes capable of detecting Cu2+ and H2S in cancer cells against interference from the tumour microenvironment remains a challenge. This study aimed to develop a novel peptide-based biosensor for monitoring Cu2+ and H2S in cancer cells and visualizing the effects of Cu2+-H2S interactions on redox homeostasis. First, we designed and synthesized the sensor NBD-DAH (NBD-Asp-Ala-His) by mimicking the Cu2+ binding site of human serum albumin (HSA). Second, we evaluated the specificity, sensitivity, and resistance of NBD-DAH to interference from the biological environment in the sequential detection of Cu2+ and H2S. Third, we investigated the binding sites and sensing mechanism between NBD-DAH and Cu2+. Finally, we evaluated the potential and biosafety of NBD-DAH for monitoring Cu2+ and H2S, visualizing their interactions in cancer cells, and exploring the effects and potential mechanisms of these interactions on redox homeostasis. NBD-DAH can specifically and sensitively detect Cu2+ and H2S in sequence through an "on-off-on" fluorescence response. Because of its high cell membrane permeability, broad pH compatibility, and rapid response, the sensor resists interferences from the complex tumor microenvironment and enables reliable detection of Cu2+ and H2S level changes in cancer cells. Furthermore, live-cell imaging with NBD-DAH revealed a molecular mechanism in which H2S specifically binds to Cu2+ in cancer cells, leading to the depletion of superoxide dismutase 1 (SOD1) activity and subsequent regulation of redox homeostasis. We developed a novel biosensor, NBD-DAH, and successfully used it to monitor Cu2+ and H2S levels and visualize their interactions in cancer cells. The interaction between Cu2+ and H2S influenced intracellular redox homeostasis, potentially through its effect on SOD1 activity.

14 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
XJXiao jie Jin
Xiao jie Jin
HZHuijuan Zhang
Huijuan Zhang
XXXiaorong Xie
Xiaorong Xie
MZMin Zhang
Min Zhang
RWRuifeng Wang
Ruifeng Wang
JYJuan Yao
Juan Yao
Astragali Radix (AR), a traditional Chinese herbal medicine, is derived from the dried roots of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao (A. membranaceus var. mongholicus, AMM) or Astragalus membranaceus (Fisch.) Bge (A. membranaceus, AM). According to traditional Chinese medicine (TCM) theory, AR is believed to tonify qi, elevate yang, consolidate the body’s surface to reduce sweating, promote diuresis and reduce swelling, generate body fluids, and nourish the blood. It has been widely used to treat general weakness and chronic illnesses and to improve overall vitality. Extensive research has identified various medicinal properties of AR, including anti-tumor, antioxidant, cardiovascular-protective, immunomodulatory, anti-inflammatory, anti-diabetic, and neuroprotective effects. With advancements in technology, methods such as computer-aided drug design (CADD) and artificial intelligence (AI) are increasingly being applied to the development of TCM. This review summarizes the progress of research on AR over the past decades, providing a comprehensive overview of its traditional efficacy, botanical characteristics, drug design and distribution, chemical constituents, and phytochemistry. This review aims to enhance researchers’ understanding of AR and its pharmaceutical potential, thereby facilitating further development and utilization.

25 April 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
GHGong Hongxia
Gong Hongxia
XJXiao jie Jin
Xiao jie Jin
LGLeng Guangxian
Leng Guangxian
ZMZhang Min
Zhang Min
NSNiu Shiwei
Niu Shiwei
LYLiu Yongqi
Liu Yongqi
Objectives. Licoflavone A (LA) is a natural flavonoid compound derived from the root of Glycyrrhiza. This study investigated the antitumor effect and underlying molecular mechanisms of LA against gastric cancer (GC) in vitro and in vivo. Materials and Methods. A CCK8 assay was used to measure the antiproliferative activity of LA in human GC SGC-7901, MKN-45, MGC-803 cells, and human GES-1 cells. Target prediction and protein-protein interaction (PPI) analysis were used to identify the potential molecular targets of LA. The binding pattern of LA to VEGFR-2 was analyzed by molecular docking and molecular dynamic (MD). The affinity of LA for VEGFR-2 was determined by microscale thermophoresis (MST). The protein tyrosine kinase activity of VEGFR-2 in the presence of LA was determined by an enzyme activity test. The effect of LA on the proliferation of VEGF-stimulated MKN-45 cells was measured with CCK8 assays, clone formation assays, and 3D microsphere models. Hoechst 33342 staining, FCM, MMP, and WB assays were used to investigate the ability of LA to block cell cycle and promote apoptosis of VEGF-stimulated MKN-45 cells. Transwell matrix assays were used to measure migration and invasion, and WB assays were used to measure EMT. Results. LA inhibited the proliferation of SGC-7901, MKN-45, and MGC-803 cells and VEGF-stimulated MKN-45 cells. VEGFR-2 was identified as the target of LA. LA could also block cell cycle, induce apoptosis, and inhibit migration, invasion, and EMT of VEGF-stimulated MKN-45 cells. Functional analyses further revealed that the cytotoxic effect of LA on VEGF-stimulated MKN-45 cells potentially involved the PI3K/AKT and MEK/ERK signaling pathways. Conclusions. This study demonstrates that LA has anti-GC potency in vitro and in vivo. LA affects the proliferation, cycle, apoptosis, migration, invasion, and EMT by targeting VEGFR-2 and blocks the PI3K/AKT and MEK/ERK signaling pathways in VEGF-stimulated MKN-45 cells.